Assertio Therapeutics (ASRT) Investor Presentation November 2021

Assertio Therapeutics outlines its strategy following the completion of workforce restructuring and Zyla Life Sciences merger integration. The company focuses on business development, sustainable growth, operating cash flow generation, and resolution of legacy legal matters to create shareholder value in the specialty pharmaceuticals sector.